Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Aaron MillerPublisher: Springer International Publishing AG Imprint: Adis Edition: 1st ed. 2017 Dimensions: Width: 12.70cm , Height: 0.90cm , Length: 20.30cm Weight: 1.855kg ISBN: 9783319406268ISBN 10: 3319406264 Pages: 134 Publication Date: 08 February 2017 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsIntroduction.- Pathogenesis and clinical presentation.- Assessment and diagnosis of relapse-remitting multiple sclerosis.- Treatment strategies.- Emerging and future treatment strategies.- Long-term management and rehabilitation.ReviewsThis is a well-considered and concise review of where we are currently `at' with relapsing-remitting multiple sclerosis. ... This is a reliable, practical introduction to the rapidly evolving and expanding area of multiple sclerosis, for those wishing to enter the -field of neurologists seeking a better understanding of it. (Victoria Singh-Curry, British Journal of Hospital Medicine, Vol. 78 (8), August, 2017) This is a well-considered and concise review of where we are currently 'at' with relapsing-remitting multiple sclerosis. ... This is a reliable, practical introduction to the rapidly evolving and expanding area of multiple sclerosis, for those wishing to enter the field of neurologists seeking a better understanding of it. (Victoria Singh-Curry, British Journal of Hospital Medicine, Vol. 78 (8), August, 2017) Author InformationDr. Aaron Miller is a member of the Board of Directors of the American Academy of Neurology, and serves as Editor of Continuum, the AAN's bimonthly continuing education publication. He is active in the New York City chapter of the National Multiple Sclerosis Society, where he serves as Chairman of the Clinical Advisory Committee. He is a past president of the Consortium of MS Centers, and was the first chairman of the Multiple Sclerosis section of the American Academy of Neurology. He has participated in numerous MS clinical trials, and is the principal investigator for several ongoing trials of new treatments at the CGD Center. Tab Content 6Author Website:Countries AvailableAll regions |
||||
